"10.1371_journal.pone.0090176","plos one","2014-02-28T00:00:00Z","Louis Yi Ann Chai; Bart Jan Kullberg; Arul Earnest; Elizabeth M Johnson; Steven Teerenstra; Alieke G Vonk; Haran T Schlamm; Raoul Herbrecht; Mihai G Netea; Peter F Troke","Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Nijmegen Institute for Infection, Inflammation and Immunity (N4i), Nijmegen, the Netherlands; Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore, Singapore; Center for Quantitative Medicine, Duke-NUS Graduate Medical School, Singapore, Singapore; Mycology Reference Laboratory, Health Protection Agency, Bristol, United Kingdom; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands; Pfizer Global Research and Development, New York, New York, United States of America; Department of Oncology and Hematology, HÃ´pitaux Universitaires de Strasbourg, Strasbourg, France; The Old Court, Broadstairs, Kent, United Kingdom","Conceived and designed the experiments: LC BJK HTS RH MGN PFT. Performed the experiments: LC EJM. Analyzed the data: LC AE ST. Contributed reagents/materials/analysis tools: EJM HTS PFT. Wrote the paper: LC BJK AGV RH MGN PFT. Oversaw galactomannan measurement performed at the Health Protection Agency Mycology Reference Laboratory, Bristol, U.K.: EMJ.","The authors have read the journals policy and have the following conflicts: L.C. has received grant support and has been advisor/consultant for Pfizer and Merck Sharp and Dohme (MSD). B.J.K. has been advisor/consultant to Pfizer, on the speakers bureau for Gilead, Pfizer and MSD, and has received research support from Cephalon. R.H. has been advisor/consultant and/or on the speakers bureau for Astellas, Basilea, Gilead, Pfizer and MSD. E.M.J. has been consultant and on the speakers bureau for Astellas, Gilead Sciences, MSD, Pfizer, Schering-Plough, and Zeneus. H.T.S. was an employee of Pfizer and P.F.T. was previously an employee of and consultant to Pfizer. All other authors: no competing financial interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Louis Yi Ann Chai","LYAC",10,TRUE,6,2,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
